Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
10.18
-0.92 (-8.29%)
At close: Dec 5, 2025, 4:00 PM EST
10.50
+0.32 (3.14%)
After-hours: Dec 5, 2025, 6:10 PM EST
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $21.13 million as of December 5, 2025. Its market cap has decreased by -21.64% in one year.
Market Cap
21.13M
Enterprise Value
17.27M
1-Year Change
-21.64%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $21.13M, a decrease of -63.67%. That is a compound annual growth rate of -29.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 21.13M | -18.18% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |